List of Addyi drug patents

Addyi is owned by Sprout Pharms.

Addyi contains Flibanserin.

Addyi has a total of 4 drug patents out of which 2 drug patents have expired.

Expired drug patents of Addyi are:

  • US9468639
  • US7420057

Addyi was authorised for market use on 18 August, 2015.

Addyi is available in tablet;oral dosage forms.

Addyi can be used as use of flibanserin or a pharmaceutically acceptable acid addition salt thereof to treat hypoactive sexual desire disorder (hsdd).

The generics of Addyi are possible to be released after 09 May, 2028.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7420057 SPROUT PHARMS Stable polymorph of flibanserin
Aug, 2022

(7 months ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9468639 SPROUT PHARMS Treating sexual desire disorders with flibanserin
Oct, 2022

(5 months ago)

US8227471 SPROUT PHARMS Treating sexual desire disorders with flibanserin
May, 2023

(a month from now)

US7151103 SPROUT PHARMS Method of treating female hypoactive sexual desire disorder with flibanserin
May, 2028

(5 years from now)

Drugs and Companies using FLIBANSERIN ingredient

Market Authorisation Date: 18 August, 2015

Treatment: Use of flibanserin or a pharmaceutically acceptable acid addition salt thereof to treat hypoactive sexual desire disorder (hsdd)

Dosage: TABLET;ORAL

More Information on Dosage

ADDYI family patents

23

United States

10

European Union

5

China

4

Brazil

4

Argentina

4

Korea, Republic of

4

Japan

2

Portugal

2

Germany

2

Malaysia

2

Spain

2

Croatia

2

New Zealand

2

Norway

2

Mexico

2

Austria

2

EA

2

South Africa

2

Canada

2

Hungary

2

Slovenia

2

Yugoslavia

2

Ukraine

2

Israel

2

Poland

2

Australia

2

Ecuador

2

Denmark

1

Colombia

1

Hong Kong

1

ME

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in